deferasirox has been researched along with Neuroblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, EJ; Chueh, HW; Kim, JY; Koo, HH; Lee, SH; Sung, KW; Yoo, KH | 1 |
| Bae, SJ; Chueh, HW; Kang, C; Koo, HH; Lee, SH; Son, MH; Sung, KW; Yoo, KH | 1 |
1 trial(s) available for deferasirox and Neuroblastoma
| Article | Year |
|---|---|
Iron chelation treatment with deferasirox prior to high-dose chemotherapy and autologous stem cell transplantation may reduce the risk of hepatic veno-occlusive disease in children with high-risk solid tumors.
Topics: Acute Kidney Injury; Benzoates; Brain Neoplasms; Child; Child, Preschool; Deferasirox; Erythrocyte Transfusion; Fanconi Syndrome; Female; Ferritins; Hepatic Veno-Occlusive Disease; Humans; Induction Chemotherapy; Infant; Iron Chelating Agents; Male; Neuroblastoma; Stem Cell Transplantation; Transplantation, Autologous; Triazoles | 2012 |
1 other study(ies) available for deferasirox and Neuroblastoma
| Article | Year |
|---|---|
Iron overload during follow-up after tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma.
Topics: Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Child; Child, Preschool; Creatinine; Deferasirox; Ferritins; Follow-Up Studies; Humans; Infant; Iron Chelating Agents; Iron Overload; Neuroblastoma; Retrospective Studies; Risk Factors; Stem Cell Transplantation; Transfusion Reaction; Transplantation, Autologous; Triazoles | 2012 |